Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MindBio Therapeutics Corp C.MBIO

MindBio Therapeutics Corp. is a biotech/biopharma company. It creates novel and emerging treatments for mental health conditions and is conducting take-home Microdosing (MB22001) human clinical trials. MB22001 is its lead candidate drug, a titratable form of Lysergic Acid Diethylamide designed for take-home microdosing. It is focused on microdosing of psychedelic medicines and is advancing its drug and technology protocols through clinical trials. It develops a multi-disciplinary platform for developing treatments and is involved in psychedelic medicine development and digital therapeutics, has completed Phase 1 clinical trials in 80 healthy participants and has completed a Phase 2a clinical trial in patients with Major Depressive Disorder. The underway are two Phase 2B trials, one in cancer patients experiencing existential distress and another in patients with Major Depressive Disorder. It invests in research that forms the basis for developing novel and clinically proven treatments.


CSE:MBIO - Post by User

Comment by Smokey1958on May 14, 2024 11:34am
96 Views
Post# 36038897

RE:Why Would Enveric Do This?

RE:Why Would Enveric Do This?This may be the "link" to MBIO I suggested in the first post. According to the Enveric website their next step for this particular formulation was in looking to do an FIH (first in human trial) in Australia. What better way to accomplish this then through a collaboration with an existing company (MBIO) that has already achieved several regulatory approvals for this type of research.

As SleepyDog said on CEO today and has repeated here before, MBIO is at the same stages of clinical trials as MindMed with a fraction of the market cap. Should MBIO start to get the same press who knows where the the sp could land in the not too distant future. It certainly doesn't hurt if this collaboration with a NASDAQ listed company comes to fruition.

GLTE!!! Always carry out your own DD!

https://www.enveric.com/pipeline/#eb-373
<< Previous
Bullboard Posts
Next >>